Frank Louis Meyskens

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Screening for cancer: valuable or not?
    Frank L Meyskens
    Department of Internal Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, 101 The City Drive, Building 56, Room 215, Route 81, Orange, CA 92868, USA
    Curr Oncol Rep 6:485-90. 2004
  2. ncbi How should we move the field of chemopreventive agent development forward in a productive manner?
    Frank Louis Meyskens
    Department of Internal Medicine Hematology Oncology and Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA 92868, USA
    Recent Results Cancer Res 166:113-24. 2005

Collaborators

Detail Information

Publications2

  1. ncbi Screening for cancer: valuable or not?
    Frank L Meyskens
    Department of Internal Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, 101 The City Drive, Building 56, Room 215, Route 81, Orange, CA 92868, USA
    Curr Oncol Rep 6:485-90. 2004
    ..The objective analysis for the major tumor types is presented in this review, but the ultimate decision on whether to be screened lies in the personal and societal arena of values...
  2. ncbi How should we move the field of chemopreventive agent development forward in a productive manner?
    Frank Louis Meyskens
    Department of Internal Medicine Hematology Oncology and Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA 92868, USA
    Recent Results Cancer Res 166:113-24. 2005
    ..We examine the problems associated with testing chemoprevention agents in humans and offer a process and guidelines that may better inform the logical development of this relatively young clinical field...